Disorders of Breast Clinical Trial
Official title:
High-Intensity Interval Training for Women at Heightened Risk for Breast Cancer
Verified date | February 2022 |
Source | M.D. Anderson Cancer Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of this research study is to learn if there is a level of exercise training that is more effective in lowering biomarker levels that are linked to breast cancer risk. Biomarkers are found in the blood/tissue and may be related to your reaction to exercise. This is an investigational study. Up to 72 participants will be enrolled in this study. All will take part at MD Anderson.
Status | Completed |
Enrollment | 39 |
Est. completion date | January 5, 2022 |
Est. primary completion date | January 5, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 55 Years |
Eligibility | Inclusion Criteria: 1. Postmenopausal women [defined per provider discretion and notated in the medical record] 2. At high risk of developing breast cancer (history of Ductal Carcinoma In Situ (DCIS), Lobular Carcinoma In Situ (LCIS), Atypical Ductal Hyperplasia (ADH), Gail 5 year risk > 1.66% or lifetime risk > 20%) 3. Enrolled on the Longitudinal High Risk Cohort study or being seen in the Cancer Prevention Center. 4. Oriented to person, place, and time 5. BMI > or equal to 25 kg/m2 6. Speaks and reads English Exclusion Criteria: 1. Underlying medical problems that contraindicate unsupervised exercise. 2. Women with a prior history of cardiovascular disease, defined as a 1 or more positive responses on the Heart Questionnaire (Appendix D). 3. Uses a walker or wheelchair/scooter 4. Is being treated for diagnosed diabetes or autoimmune disease 5. Lives outside the greater Houston area (Harris and contiguous counties) 6. Is pregnant (self-reported) 7. Is taking risk reduction therapy such as tamoxifen 8. Participants with a blood pressure >=140/90 at the time of baseline testing. |
Country | Name | City | State |
---|---|---|---|
United States | University of Texas MD Anderson Cancer Center | Houston | Texas |
Lead Sponsor | Collaborator |
---|---|
M.D. Anderson Cancer Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility of High-Intensity Interval Exercise to Offset the Tumor Promoting Effects of Obesity in High-Risk Breast Cancer Participants | Trials judged feasible if:
At least 45% of screened patients meet inclusion criteria, 2. At least 50% of patients who meet the inclusion criteria consent, 3. Adherence in HIIT and MICT is larger than 80%, and 4. Retention rate is larger than 80%. |
12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03019445 -
Magseed and Sentimag in Surgical Excision of Breast Lesions
|
Phase 4 | |
Completed |
NCT03020888 -
Magseed Magnetic Marker Localization
|
N/A |